Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cellosaurus is database indexing available cell lines from various collections: American Type Culture Collection (ATCC), Bioresource Collection and Research Center, Taiwan (BCRC), Banco de Células do Rio de Janeiro (BCRJ), CellBank Australia (CBA), Collection of Cell Lines in Veterinary Medicine (CCLV), Cell Lines Service (CLS), Coriell, Drosophila Genomics Resource Center (DGRC), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), European Bank for induced pluripotent Stem Cells (EBiSC), European Collection of Authenticated Cell Cultures (ECACC), Interlab Cell Line Collection (ICLC), Institute for Fermentation Osaka (IFO), Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) biobank, Japanese Collection of Research Bioresources (JCRB) Cell Bank, Kunming Cell Bank of Type Culture Collection (KCB), Korean Cell Line Bank (KCLB), Millipore, National Cell Bank of Iran (NCBI_Iran), National Cancer Institute - Developmental Therapeutics Program (NCI-DTP), NINDS Human Cell and Data Repository (NHCDR), NIH AIDS Reagent Program (NIH-ARP), NISES, RIKEN Bioresource Center Cell Bank (RCB), Royan Stem Cell Bank (RSCB), Tick Cell Biobank (TCB), Tohoku University cell line catalog (TKG), and Ximbio.
| Name | Proper Citation | Organism | Disease |
Comments |
Defining Citation | Category | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HCT 116 shPARG Resource Report Resource Website |
RRID:CVCL_QZ52 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | PMID:23955771 | Cancer cell line | Male | shPARG HCT116 | cancercelllines:CVCL_QZ52, Wikidata:Q54881983 |
cvcl_0291 | CVCL_QZ52 | 2026-02-07 08:14:19 | 0 | |||
|
HCT 116 EP300(-) clone D10 Resource Report Resource Website |
RRID:CVCL_HG27 | Homo sapiens (Human) | Colon carcinoma | Characteristics: HCT 116 is hemizygous for EP300. This cell line is KO for the single allele., Population: Caucasian. | PMID:15123817 | Cancer cell line | Male | HCT 116 p300 KO Clone D10, HCT 116 p300 KO [D10], p300 KO Clone D10 | cancercelllines:CVCL_HG27, CancerTools:151479, ECACC:17011201, Wikidata:Q54881934, Ximbio:151479 |
cvcl_hg26 | CVCL_HG27 | 2026-02-07 08:14:10 | 0 | |||
|
HCT 116 AXL KO Tet-inducible Resource Report Resource Website |
RRID:CVCL_HG04 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | PMID:24170546 | Cancer cell line | Male | cancercelllines:CVCL_HG04, CancerTools:153206, Wikidata:Q54881912, Ximbio:153206 |
cvcl_0291 | CVCL_HG04 | 2026-02-07 08:14:09 | 0 | ||||
|
HCT 116 CTNNB1(+/-) Resource Report Resource Website |
RRID:CVCL_HD74 | Homo sapiens (Human) | Colon carcinoma | Characteristics: In HCT 116 one of the two CTNNB1 alleles has a 3-bp deletion that eliminates S-45. This cell line is KO for the mutant allele., Population: Caucasian. | PMID:12060769 | Cancer cell line | Male | CTNNB1 (+/-) HCT116, CTNNB1 WT/- HCT116 | cancercelllines:CVCL_HD74, Horizon_Discovery:HD+104-009, Wikidata:Q54881928 |
cvcl_0291 | CVCL_HD74 | 2026-02-07 08:14:18 | 0 | |||
|
HCT 116 TP53(-/-) Resource Report Resource Website 10+ mentions |
RRID:CVCL_HD97 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. |
PMID:19225112 PMID:29045385 |
Cancer cell line | Male | TP53 (-/-) HCT116, HCT116-p53-null, Hct116_p53_knockout | cancercelllines:CVCL_HD97, GEO:GSM383865, GEO:GSM383866, GEO:GSM384089, GEO:GSM384090, Horizon_Discovery:HD+104-001, Wikidata:Q54881988 |
cvcl_0291 | CVCL_HD97 | 2026-02-07 08:14:19 | 12 | |||
|
HCT 116 NFE2L2 (E79K/+) Resource Report Resource Website |
RRID:CVCL_LD98 | Homo sapiens (Human) | Colon carcinoma | Characteristics: Heterozygous knockin of a NFE2L2 activating mutation., Population: Caucasian. | Cancer cell line | Male | NFE2L2 (E79K/+) HCT116 | cancercelllines:CVCL_LD98, Horizon_Discovery:HD+104-095, Wikidata:Q54881966 |
cvcl_0291 | CVCL_LD98 | 2026-02-07 08:14:11 | 0 | ||||
|
HCT 116 FLT3 (D835Y/+) Resource Report Resource Website |
RRID:CVCL_LD90 | Homo sapiens (Human) | Colon carcinoma | Characteristics: Heterozygous knockin of a FLT3 activating mutation., Population: Caucasian. | Cancer cell line | Male | FLT3 (D835Y/+) HCT116 | cancercelllines:CVCL_LD90, Horizon_Discovery:HD+104-041, Wikidata:Q54881943 |
cvcl_0291 | CVCL_LD90 | 2026-02-07 08:14:03 | 0 | ||||
|
HCT 116 APOC1(-/-) Resource Report Resource Website |
RRID:CVCL_HD68 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | Cancer cell line | Male | APOC1 (-/-) HCT116 | cancercelllines:CVCL_HD68, Horizon_Discovery:HD+R02-007, Wikidata:Q54881911 |
cvcl_0291 | CVCL_HD68 | 2026-02-07 08:14:03 | 0 | ||||
|
HCT 116 PDPK1(+/-) Resource Report Resource Website |
RRID:CVCL_HD87 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | PMID:20133737 | Cancer cell line | Male | PDPK1 (+/-) HCT116 | cancercelllines:CVCL_HD87, Horizon_Discovery:HD+R02-080, Wikidata:Q54881973 |
cvcl_0291 | CVCL_HD87 | 2026-02-07 08:14:11 | 0 | |||
|
HCT 116 SYT1 KO Resource Report Resource Website |
RRID:CVCL_B3P8 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian., From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada. | PMID:39169954 | Cancer cell line | Male | cancercelllines:CVCL_B3P8, Wikidata:Q110432846 |
cvcl_0291 | CVCL_B3P8 | 2026-02-07 08:14:11 | 0 | ||||
|
HCT 116 Resource Report Resource Website 10000+ mentions |
RRID:CVCL_0291 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: JFCR39 cancer cell line panel., Part of: FGFR genetic alteration cell panel (ATCC TCP-1034)., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel. |
PMID:2041050 PMID:2835152 PMID:3335022 PMID:3955419 PMID:6437669 PMID:7214343 PMID:7761852 PMID:7824277 PMID:7972006 PMID:9000147 PMID:9000572 PMID:9023415 PMID:9174048 PMID:9178645 PMID:9294210 PMID:9331090 PMID:9515795 PMID:9563901 PMID:9715273 PMID:10612807 PMID:10674020 PMID:10700174 PMID:10700188 PMID:10737795 PMID:11226274 PMID:11314036 PMID:11414198 PMID:11416159 PMID:11526487 PMID:11687795 PMID:12068308 PMID:12584437 PMID:12615714 PMID:12671075 PMID:12714694 PMID:15748285 PMID:15900046 PMID:16418264 PMID:16854228 PMID:17088437 PMID:17178751 PMID:17363507 PMID:18258742 PMID:18340113 PMID:19372543 PMID:19927377 PMID:20164919 PMID:20215515 PMID:20570890 PMID:20606684 PMID:21912889 PMID:22068913 PMID:22336246 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23272949 PMID:23546019 PMID:23631600 PMID:23649806 PMID:23671654 PMID:23856246 PMID:23933261 PMID:24042735 PMID:24279929 PMID:24670534 PMID:24755471 PMID:25485619 PMID:25576301 PMID:25841592 PMID:25877200 PMID:25926053 PMID:25944804 PMID:25960936 PMID:25984343 PMID:26169745 PMID:26537799 PMID:26589293 PMID:26719794 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28179481 PMID:28192450 PMID:28196595 PMID:28601559 PMID:28683746 PMID:28854368 PMID:29101300 PMID:29207035 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31733513 PMID:31978347 PMID:32172478 PMID:32927768 PMID:34320349 PMID:35839778 PMID:36648961 PMID:38861359 |
Cancer cell line | Male | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 | BTO:BTO_0001109, CLO:CLO_0003665, EFO:EFO_0002824, MCCL:MCC:0000181, CLDB:cl1574, CLDB:cl1575, CLDB:cl5198, 4DN:4DNSRMYUIVGD, Abcam:ab255451, Abcam:ab273730, Abcam:ab288559, ABM:T8240, AddexBio:C0009005/41, ArrayExpress:E-MEXP-2623, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-5197, ATCC:CCL-247, BCRC:60349, BCRJ:0288, BioGRID_ORCS_Cell_line:97, BioSample:SAMN03470980, BioSample:SAMN03471481, BioSample:SAMN03473487, BioSample:SAMN05292433, BioSample:SAMN10988251, cancercelllines:CVCL_0291, CCRID:1101HUM-PUMC000158, CCRID:1101HUM-PUMC000331, CCRID:3101HUMTCHu99, CCRID:4201HUM-CCTCC00625, Cell_Model_Passport:SIDM00783, ChEMBL-Cells:CHEMBL3308372, ChEMBL-Targets:CHEMBL394, CLS:300195, ColonAtlas:HCT116, Cosmic:711257, Cosmic:720329, Cosmic:724840, Cosmic:869794, Cosmic:870449, Cosmic:873701, Cosmic:875296, Cosmic:875425, Cosmic:875847, Cosmic:876644, Cosmic:876706, Cosmic:887223, Cosmic:889535, Cosmic:897457, Cosmic:902790, Cosmic:905936, Cosmic:913887, Cosmic:934564, Cosmic:947355, Cosmic:948126, Cosmic:948861, Cosmic:985996, Cosmic:995410, Cosmic:1043815, Cosmic:1044257, Cosmic:1045410, Cosmic:1057752, Cosmic:1066205, Cosmic:1067220, Cosmic:1092600, Cosmic:1102383, Cosmic:1122325, Cosmic:1131683, Cosmic:1132568, Cosmic:1132689, Cosmic:1154644, Cosmic:1175840, Cosmic:1176588, Cosmic:1183769, Cosmic:1184080, Cosmic:1184333, Cosmic:1187306, Cosmic:1218874, Cosmic:1223141, Cosmic:1305353, Cosmic:1310945, Cosmic:1332008, Cosmic:1436021, Cosmic:1466804, Cosmic:1466815, Cosmic:1479594, Cosmic:1486132, Cosmic:1519359, Cosmic:1524003, Cosmic:1524333, Cosmic:1552179, Cosmic:1571772, Cosmic:1609495, Cosmic:1672408, Cosmic:1676727, Cosmic:1708402, Cosmic:1805253, Cosmic:1927246, Cosmic:1945865, Cosmic:1995437, Cosmic:1998442, Cosmic:2036656, Cosmic:2046556, Cosmic:2052593, Cosmic:2145576, Cosmic:2301978, Cosmic:2389569, Cosmic:2433755, Cosmic:2464667, Cosmic:2550353, Cosmic:2646766, Cosmic:2651864, Cosmic:2667881, Cosmic:2667972, Cosmic:2668248, Cosmic:2727479, Cosmic:2760068, Cosmic:2787545, Cosmic:2811054, Cosmic-CLP:905936, DepMap:ACH-000971, DSMZ:ACC-581, DSMZCellDive:ACC-581, ECACC:91091005, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, ENCODE:ENCBS004UZY, ENCODE:ENCBS009DQE, ENCODE:ENCBS257IHV, ENCODE:ENCBS378ENC, ENCODE:ENCBS389ENC, ENCODE:ENCBS409ENC, ENCODE:ENCBS409MTT, ENCODE:ENCBS431ENC, ENCODE:ENCBS471AAA, ENCODE:ENCBS472AAA, ENCODE:ENCBS475AAA, ENCODE:ENCBS476AAA, ENCODE:ENCBS494OPB, ENCODE:ENCBS615KTO, ENCODE:ENCBS626JHZ, ENCODE:ENCBS650OZU, ENCODE:ENCBS847SOB, ENCODE:ENCBS851PYB, GDSC:905936, GEO:GSM810, GEO:GSM2143, GEO:GSM50188, GEO:GSM50252, GEO:GSM115118, GEO:GSM206501, GEO:GSM274713, GEO:GSM274714, GEO:GSM274726, GEO:GSM383862, GEO:GSM383867, GEO:GSM383868, GEO:GSM384091, GEO:GSM384092, GEO:GSM481405, GEO:GSM513818, GEO:GSM514292, GEO:GSM580039, GEO:GSM580040, GEO:GSM741266, GEO:GSM743443, GEO:GSM749774, GEO:GSM750773, GEO:GSM750793, GEO:GSM784012, GEO:GSM799331, GEO:GSM799394, GEO:GSM827446, GEO:GSM846355, GEO:GSM887062, GEO:GSM888132, GEO:GSM945287, GEO:GSM945304, GEO:GSM1022651, GEO:GSM1022652, GEO:GSM1153399, GEO:GSM1178133, GEO:GSM1178134, GEO:GSM1178135, GEO:GSM1181250, GEO:GSM1181367, GEO:GSM1346874, GEO:GSM1374516, GEO:GSM1374517, GEO:GSM1374518, GEO:GSM1404391, GEO:GSM1404392, GEO:GSM1448092, GEO:GSM1669868, GEO:GSM2124655, GEO:GSM2550001, GEO:GSM3145712, GEO:GSM3591761, IARC_TP53:21064, ICLC:HTL95025, IZSLER:BS TCL 100, KCB:KCB 200706YJ, KCLB:10247, LiGeA:CCLE_168, LINCS_LDP:LCL-1161, Lonza:691, MeSH:D045325, MetaboLights:MTBLS227, NCBI_Iran:C570, NCI-DTP:HCT-116, PharmacoDB:HCT116_517_2019, PRIDE:PXD000089, PRIDE:PXD000394, PRIDE:PXD001352, PRIDE:PXD001426, PRIDE:PXD001546, PRIDE:PXD001550, PRIDE:PXD002453, PRIDE:PXD002793, PRIDE:PXD003539, PRIDE:PXD004452, PRIDE:PXD005235, PRIDE:PXD005354, PRIDE:PXD005355, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD025898, PRIDE:PXD030304, PRIDE:PXD032264, PRIDE:PXD037651, Progenetix:CVCL_0291, PubChem_Cell_line:CVCL_0291, RCB:RCB2979, SKY/M-FISH/CGH:1687, SKY/M-FISH/CGH:2778, SKY/M-FISH/CGH:2785, SKY/M-FISH/CGH:3883, TOKU-E:1422, Ubigene:YC-C004, Wikidata:Q28334584 |
CVCL_0291 | 2026-02-07 08:14:03 | 15536 | ||||
|
HCT 116 PDGFRA (D842V/+) Resource Report Resource Website |
RRID:CVCL_LE00 | Homo sapiens (Human) | Colon carcinoma | Characteristics: Heterozygous knockin of a PDGFRA activating mutation., Population: Caucasian. | Cancer cell line | Male | PDGFRA (D842V/+) HCT116 | cancercelllines:CVCL_LE00, Horizon_Discovery:HD+104-064, Wikidata:Q54881972 |
cvcl_0291 | CVCL_LE00 | 2026-02-07 08:14:04 | 0 | ||||
|
HCT 116 KDM5A(+/-) Resource Report Resource Website |
RRID:CVCL_HD79 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | Cancer cell line | Male | KDM5A (+/-) HCT116 | cancercelllines:CVCL_HD79, Horizon_Discovery:HD+104-053, Wikidata:Q54881956 |
cvcl_0291 | CVCL_HD79 | 2026-02-07 08:14:04 | 0 | ||||
|
HCT 116 CDK2(-/-) Resource Report Resource Website |
RRID:CVCL_HD72 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | PMID:20195506 | Cancer cell line | Male | CDK2 (-/-) HCT116, CDK2-/- HCT116 | cancercelllines:CVCL_HD72, Horizon_Discovery:HD+R02-015, Wikidata:Q54881925 |
cvcl_0291 | CVCL_HD72 | 2026-02-07 08:14:18 | 0 | |||
|
HCT 116 PPARD(-/-) Resource Report Resource Website |
RRID:CVCL_HD88 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | PMID:11226285 | Cancer cell line | Male | PPARD (-/-) HCT116, HCT116 PPARdelta -/- | cancercelllines:CVCL_HD88, Horizon_Discovery:HD+R02-038, Wikidata:Q54881976 |
cvcl_0291 | CVCL_HD88 | 2026-02-07 08:14:11 | 0 | |||
|
HCT 116 FGFR2 (S252W/+/+) Resource Report Resource Website |
RRID:CVCL_LD88 | Homo sapiens (Human) | Colon carcinoma | Characteristics: Heterozygous knockin of a FGFR2 activating mutation., Population: Caucasian. | Cancer cell line | Male | FGFR2 (S252W/+/+) HCT116 | cancercelllines:CVCL_LD88, Horizon_Discovery:HD+104-030, Wikidata:Q54881941 |
cvcl_0291 | CVCL_LD88 | 2026-02-07 08:14:10 | 0 | ||||
|
HCT 116 FGFR3 (S249C/+) Resource Report Resource Website |
RRID:CVCL_LD89 | Homo sapiens (Human) | Colon carcinoma | Characteristics: Heterozygous knockin of a FGFR3 activating mutation., Population: Caucasian. | Cancer cell line | Male | FGFR3 (S249C/+) HCT116 | cancercelllines:CVCL_LD89, Horizon_Discovery:HD+104-044, Wikidata:Q54881942 |
cvcl_0291 | CVCL_LD89 | 2026-02-07 08:14:18 | 0 | ||||
|
HCT 116 GNAQ (Q209L/+) Resource Report Resource Website |
RRID:CVCL_LD92 | Homo sapiens (Human) | Colon carcinoma | Characteristics: Heterozygous knockin of a GNAQ activating mutation., Population: Caucasian. | Cancer cell line | Male | GNAQ (Q209L/+) HCT116 | cancercelllines:CVCL_LD92, Horizon_Discovery:HD+104-045, Wikidata:Q54881945 |
cvcl_0291 | CVCL_LD92 | 2026-02-07 08:14:18 | 0 | ||||
|
HCT 116 DICER1(-/-) Resource Report Resource Website 1+ mentions |
RRID:CVCL_HD76 | Homo sapiens (Human) | Colon carcinoma | Population: Caucasian. | PMID:16505370 | Cancer cell line | Male | DICER1 (-/-) HCT116 | cancercelllines:CVCL_HD76, Horizon_Discovery:HD+R02-019, Wikidata:Q54881931 |
cvcl_0291 | CVCL_HD76 | 2026-02-07 08:14:10 | 1 | |||
|
HCT 116 MET (Y1253D/+) Resource Report Resource Website |
RRID:CVCL_LD96 | Homo sapiens (Human) | Colon carcinoma | Characteristics: Heterozygous knockin of a MET activating mutation., Population: Caucasian. | Cancer cell line | Male | MET (Y1253D/+) HCT116 | cancercelllines:CVCL_LD96, Horizon_Discovery:HD+104-056, Wikidata:Q54881963 |
cvcl_0291 | CVCL_LD96 | 2026-02-07 08:14:11 | 0 |
Can't find your Cell Line?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
